Cargando…

Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis

Analogue-sensitive (as) mutants of kinases are widely used to selectively inhibit a single kinase with few off-target effects. The analogue-sensitive mutant cdc2-as of fission yeast (Schizosaccharomyces pombe) is a powerful tool to study the cell cycle, but the strain displays meiotic defects, and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoi, Yuki, Kawashima, Shigehiro A., Simanis, Viesturs, Yamamoto, Masayuki, Sato, Masamitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118601/
https://www.ncbi.nlm.nih.gov/pubmed/24990387
http://dx.doi.org/10.1098/rsob.140063
_version_ 1782328865438302208
author Aoi, Yuki
Kawashima, Shigehiro A.
Simanis, Viesturs
Yamamoto, Masayuki
Sato, Masamitsu
author_facet Aoi, Yuki
Kawashima, Shigehiro A.
Simanis, Viesturs
Yamamoto, Masayuki
Sato, Masamitsu
author_sort Aoi, Yuki
collection PubMed
description Analogue-sensitive (as) mutants of kinases are widely used to selectively inhibit a single kinase with few off-target effects. The analogue-sensitive mutant cdc2-as of fission yeast (Schizosaccharomyces pombe) is a powerful tool to study the cell cycle, but the strain displays meiotic defects, and is sensitive to high and low temperature even in the absence of ATP-analogue inhibitors. This has limited the use of the strain for use in these settings. Here, we used in vivo selection for intragenic suppressor mutations of cdc2-as that restore full function in the absence of ATP-analogues. The cdc2-asM17 underwent meiosis and produced viable spores to a similar degree to the wild-type strain. The suppressor mutation also rescued the sensitivity of the cdc2-as strain to high and low temperature, genotoxins and an anti-microtubule drug. We have used cdc2-asM17 to show that Cdc2 activity is required to maintain the activity of the spindle assembly checkpoint. Furthermore, we also demonstrate that maintenance of the Shugoshin Sgo1 at meiotic centromeres does not require Cdc2 activity, whereas localization of the kinase aurora does. The modified cdc2-asM17 allele can be thus used to analyse many aspects of cell-cycle-related events in fission yeast.
format Online
Article
Text
id pubmed-4118601
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-41186012014-08-11 Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis Aoi, Yuki Kawashima, Shigehiro A. Simanis, Viesturs Yamamoto, Masayuki Sato, Masamitsu Open Biol Research Analogue-sensitive (as) mutants of kinases are widely used to selectively inhibit a single kinase with few off-target effects. The analogue-sensitive mutant cdc2-as of fission yeast (Schizosaccharomyces pombe) is a powerful tool to study the cell cycle, but the strain displays meiotic defects, and is sensitive to high and low temperature even in the absence of ATP-analogue inhibitors. This has limited the use of the strain for use in these settings. Here, we used in vivo selection for intragenic suppressor mutations of cdc2-as that restore full function in the absence of ATP-analogues. The cdc2-asM17 underwent meiosis and produced viable spores to a similar degree to the wild-type strain. The suppressor mutation also rescued the sensitivity of the cdc2-as strain to high and low temperature, genotoxins and an anti-microtubule drug. We have used cdc2-asM17 to show that Cdc2 activity is required to maintain the activity of the spindle assembly checkpoint. Furthermore, we also demonstrate that maintenance of the Shugoshin Sgo1 at meiotic centromeres does not require Cdc2 activity, whereas localization of the kinase aurora does. The modified cdc2-asM17 allele can be thus used to analyse many aspects of cell-cycle-related events in fission yeast. The Royal Society 2014-07-02 /pmc/articles/PMC4118601/ /pubmed/24990387 http://dx.doi.org/10.1098/rsob.140063 Text en http://creativecommons.org/licenses/by/3.0/ © 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Research
Aoi, Yuki
Kawashima, Shigehiro A.
Simanis, Viesturs
Yamamoto, Masayuki
Sato, Masamitsu
Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis
title Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis
title_full Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis
title_fullStr Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis
title_full_unstemmed Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis
title_short Optimization of the analogue-sensitive Cdc2/Cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis
title_sort optimization of the analogue-sensitive cdc2/cdk1 mutant by in vivo selection eliminates physiological limitations to its use in cell cycle analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118601/
https://www.ncbi.nlm.nih.gov/pubmed/24990387
http://dx.doi.org/10.1098/rsob.140063
work_keys_str_mv AT aoiyuki optimizationoftheanaloguesensitivecdc2cdk1mutantbyinvivoselectioneliminatesphysiologicallimitationstoitsuseincellcycleanalysis
AT kawashimashigehiroa optimizationoftheanaloguesensitivecdc2cdk1mutantbyinvivoselectioneliminatesphysiologicallimitationstoitsuseincellcycleanalysis
AT simanisviesturs optimizationoftheanaloguesensitivecdc2cdk1mutantbyinvivoselectioneliminatesphysiologicallimitationstoitsuseincellcycleanalysis
AT yamamotomasayuki optimizationoftheanaloguesensitivecdc2cdk1mutantbyinvivoselectioneliminatesphysiologicallimitationstoitsuseincellcycleanalysis
AT satomasamitsu optimizationoftheanaloguesensitivecdc2cdk1mutantbyinvivoselectioneliminatesphysiologicallimitationstoitsuseincellcycleanalysis